Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

albemarle corp. - ALB

ALB

Close Chg Chg %
109.58 0.40 0.36%

Open Market

109.98

+0.40 (0.36%)

Volume: 846.45K

Last Updated:

Nov 21, 2024, 2:05 PM EDT

Trade Now

Company Overview: albemarle corp. - ALB

ALB Key Data

Open

$107.86

 Day Range

106.47 - 110.04

52 Week Range

71.97 - 153.54

 Market Cap

$12.88B

Shares Outstanding

117.54M

 Public Float

117.02M

Beta

1.55

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$16.75

Yield

146.51%

 Dividend

$0.41

EX-DIVIDEND DATE

Dec 13, 2024

 SHORT INTEREST

N/A

AVERAGE VOLUME

2.36M

  

ALB Performance

1 Week
 
 5.81%
 
1 Month
 
 15.15%
 
3 Months
 
 21.05%
 
1 Year
 
 -14.99%
 
5 Years
 
 68.80%
 

ALB Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 27
Full Ratings ➔

About albemarle corp. - ALB

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, Ketjen, and All Other. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The All Other segment refers only to the FCS business that did not fit into any of the company’s core businesses. The company was founded in 1993 and is headquartered in Charlotte, NC.

ALB At a Glance

Albemarle Corp.
4250 Congress Street
Charlotte, North Carolina 28209
Phone 1-980-299-5700 Revenue 9.62B
Industry Chemicals: Specialty Net Income 1.57B
Sector Process Industries 2023 Sales Growth 31.381%
Fiscal Year-end 12 / 2024 Employees 9,000
View SEC Filings

ALB Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 10.814
Price to Sales Ratio 1.769
Price to Book Ratio 1.801
Price to Cash Flow Ratio 12.838
Enterprise Value to EBITDA 30.83
Enterprise Value to Sales 2.151
Total Debt to Enterprise Value 0.208

ALB Efficiency

Revenue/Employee 1,068,578.111
Income Per Employee 174,830.667
Receivables Turnover 5.24
Total Asset Turnover 0.57

ALB Liquidity

Current Ratio 1.465
Quick Ratio 0.858
Cash Ratio 0.25

ALB Profitability

Gross Margin 12.488
Operating Margin 2.507
Pretax Margin 2.566
Net Margin 16.361
Return on Assets 9.331
Return on Equity 18.091
Return on Total Capital 11.466
Return on Invested Capital 12.917

ALB Capital Structure

Total Debt to Total Equity 45.803
Total Debt to Total Capital 31.414
Total Debt to Total Assets 23.595
Long-Term Debt to Equity 38.829
Long-Term Debt to Total Capital 26.631
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Albemarle Corp. - ALB

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
3.13B 3.33B 7.32B 9.62B
Sales Growth
-12.83% +6.36% +119.96% +31.38%
Cost of Goods Sold (COGS) incl D&A
2.13B 2.32B 4.23B 8.42B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
231.98M 254.00M 300.84M 429.94M
Depreciation
207.06M 228.67M 276.13M 401.92M
Amortization of Intangibles
24.92M 25.33M 24.71M 28.03M
COGS Growth
-8.47% +8.72% +82.56% +98.75%
Gross Income
995.55M 1.01B 3.09B 1.20B
Gross Income Growth
-20.91% +1.30% +205.97% -61.08%
Gross Profit Margin
+31.82% +30.30% +42.15% +12.49%
2020 2021 2022 2023 5-year trend
SG&A Expense
469.84M 475.81M 584.13M 959.89M
Research & Development
59.21M 54.03M 71.98M 85.72M
Other SG&A
410.63M 421.79M 512.14M 874.16M
SGA Growth
-18.07% +1.27% +22.76% +64.33%
Other Operating Expense
- - - -
-
Unusual Expense
25.07M 54.08M 87.61M (171.35M)
EBIT after Unusual Expense
500.65M 478.58M 2.41B 412.47M
Non Operating Income/Expense
(54.01M) (309.81M) 130.74M (49.66M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
73.12M 35.14M 111.15M 116.07M
Interest Expense Growth
+38.30% -51.93% +216.28% +4.43%
Gross Interest Expense
103.52M 85.14M 142.25M 188.77M
Interest Capitalized
30.40M 50.00M 31.10M 72.70M
Pretax Income
373.52M 133.62M 2.43B 246.74M
Pretax Income Growth
-33.65% -64.23% +1,721.19% -89.86%
Pretax Margin
+11.94% +4.02% +33.24% +2.57%
Income Tax
54.42M 29.45M 390.59M 430.28M
Income Tax - Current - Domestic
(333.00K) 12.42M 38.20M (57.65M)
Income Tax - Current - Foreign
56.73M 55.53M 259.05M 387.05M
Income Tax - Deferred - Domestic
1.67M (43.96M) 80.54M (12.70M)
Income Tax - Deferred - Foreign
(3.65M) 5.46M 12.80M 113.58M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
446.62M 199.94M 2.82B 1.67B
Minority Interest Expense
70.85M 76.27M 125.31M 97.07M
Net Income
375.76M 123.67M 2.69B 1.57B
Net Income Growth
-29.53% -67.09% +2,074.96% -41.50%
Net Margin Growth
+12.01% +3.72% +36.75% +16.36%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
375.76M 123.67M 2.69B 1.57B
Preferred Dividends
- - - -
-
Net Income Available to Common
375.76M 123.67M 2.69B 1.57B
EPS (Basic)
3.5316 1.0676 22.9663 13.4122
EPS (Basic) Growth
-29.83% -69.77% +2,051.21% -41.60%
Basic Shares Outstanding
106.40M 115.84M 117.12M 117.32M
EPS (Diluted)
3.5181 1.0612 22.8351 13.361
EPS (Diluted) Growth
-29.85% -69.84% +2,051.82% -41.49%
Diluted Shares Outstanding
106.81M 116.54M 117.79M 117.77M
EBITDA
757.70M 786.66M 2.80B 671.07M
EBITDA Growth
-15.70% +3.82% +256.23% -76.05%
EBITDA Margin
+24.22% +23.64% +38.28% +6.98%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 112.238
Number of Ratings 27 Current Quarters Estimate -0.637
FY Report Date 12 / 2024 Current Year's Estimate -1.571
Last Quarter’s Earnings -1.55 Median PE on CY Estimate N/A
Year Ago Earnings 22.25 Next Fiscal Year Estimate 0.905
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 19 11 21 21
Mean Estimate -0.64 -0.32 -1.57 0.91
High Estimates 0.58 0.66 2.35 5.40
Low Estimate -1.28 -1.58 -2.53 -4.30
Coefficient of Variance -64.29 -246.74 -67.08 278.17

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 9 10 11
OVERWEIGHT 1 0 1
HOLD 14 16 15
UNDERWEIGHT 1 0 0
SELL 2 2 2
MEAN Overweight Overweight Overweight

Insider Actions for Albemarle Corp. - ALB

Date Name Shares Transaction Value
Jul 4, 2024 Ralf H. Cramer Director 3,232 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.41 per share 314,829.12
Jul 4, 2024 Holly Ann van Deursen Director 5,842 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Alejandro D. Wolff Director 12,502 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Diarmuid B. O'Connell Director 9,181 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Ralf H. Cramer Director 3,481 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Ralf H. Cramer Director 3,226 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.41 per share 314,244.66
Jul 4, 2024 Ralf H. Cramer Director 3,236 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Alejandro D. Wolff Director 12,492 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 James J. O'Brien Director 5,313 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Dean L. Seavers Director 9,259 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Dean L. Seavers Director 9,249 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Mary Lauren Brlas Director 3,241 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Mary Lauren Brlas Director 3,231 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Diarmuid B. O'Connell Director 9,191 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Glenda J. Minor Director 5,856 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 Gerald A. Steiner Director 8,250 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 4, 2024 James J. O'Brien Director 5,323 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 16, 2024 Mark Richard Mummert SVP, Capital Projects 6,802 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $135.53 per share 921,875.06
May 15, 2024 John Clarence Barichivich VP, Controller & CAO 4,743 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $132.17 per share 626,882.31
Mar 4, 2024 Eric W. Norris President, Energy Storage 34,842 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $132.06 per share 4,601,234.52

Albemarle Corp. in the News